Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Phase 1 clinical trial for the safety and dose determination of Pneumostem (human umbilical
cord blood derived mesenchymal stem cells) in the premature infants with intraventricular
hemorrhage (IVH, grade 3-4)